Interesting article out of the New England Journal of Medicine entitled The Role of Public-Sector Research in the Discovery of Drugs and Vaccines.
Findings:
We found that during the past 40 years, 153 new FDA-approved drugs, vaccines, or new indications for existing drugs were discovered through research carried out in PSRIs [public-sector research institutions]. These drugs included 93 small-molecule drugs, 36 biologic agents, 15 vaccines, 8 in vivo diagnostic materials, and 1 over-the-counter drug. More than half of these drugs have been used in the treatment or prevention of cancer or infectious diseases. PSRI-discovered drugs are expected to have a disproportionately large therapeutic effect. (Brackets added)
Filed under: Uncategorized | Tagged: biologic agents, drugs, FDA approved drugs, in vivo diagnostic materials, New England Journal of Medicine, over-the-counter drg, prevention of cancer, prevention of infectious diseases, public sector research, small-molecule drugs, vaccines |
Patently BIOtech 
Leave a Reply